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The statistical association of certain anaerobic organisms such as black pigmented
baeteroides (BPB) species and spirochetes with clinical signs of active Periodontitis, i.e.
bleeding upon probing and bone loss, suggests that the lesions may actually reflect a "specific
infection" involving these or unidentified species. All the known oral species of BPB and
spirochetes are anaerobes which suggests that antimicrobial treatment directed specifically
against anaerobes might be effective in periodontal therapy. In this report, the short-term
results of metronidazole treatment plus mechanical debridement in patients with extensive
periodontal disease and of a double-blind clinical study in which metronidazole plus
mechanical debridement is compared to placebo plus mechanical debridement are described.
The findings indicate that 1 week of systemic metronidazole can optimize the clinical
reduction of pockets and increase the apparent attachment in Periodontitis patients who
receive concurrent mechanical debridement of their root surfaces. In patients with extensive
clinical involvement, metronidazole resulted in a significant reduction in the number of sites
exhibiting pocket depths and attachment loss >7 mm. When metronidazole plus mechanical
debridement was compared with placebo plus mechanical debridement in a double-blind
study, the metronidazole patients exhibited a significant improvement in those sites initially
>7 mm. The beneficial effect of the metronidazole was associated with a significant and
sustained reduction of certain anaerobic organisms such as Baeteroides gingivalis and the
large spirochetes. These data indicate that treatment aimed specifically toward the anaerobic
component of the plaque flora can be associated with impressive clinical improvements 15
to 30 weeks after the initiation of treatment.
Periodontal disease is the foremost cause of tooth
loss in adult populations.' In recent years the essential
role of bacterial plaque in initiating and propagating a
host inflammatory response in the periodontal tissues
has been documented both in experimental gingivitis
in humans2-3 and in Periodontitis in animals.4"6 More-
over there appears to be an element of bacterial speci-
ficity in these periodontal infections as spirochetes78
and black pigmented baeteroides (BPB)910 are signifi-
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cantly elevated in plaques removed from sites of active
Periodontitis, and Actinobacillus actinomycetemcomi-
tans is either present, or in high proportions in plaques
taken from sites of bone loss in patients diagnosed as
exhibiting localized juvenile Periodontitis1112 or rapidly
progressing Periodontitis.13 Peripheral blood taken from
periodontal patients reveals significant increases in spe-
cific antibodies to the above organisms.1415
The statistical association of certain organisms with
clinical signs of active disease, i.e., bleeding upon prob-
ing and bone loss, suggests that the observed lesions
may actually reflect a "specific infection" involving
these or possibly unidentified bacterial species. These
observations led to the formulation of the specific
plaque hypothesis (SPH), which views certain plaques
as being periodontopathic because they are colonized
and/or dominated by one or more bacterial types.
These bacterial types are presumed, on the basis of
association-type data and animal studies, to be respon-
sible for a measurable amount of periodontal tissue
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destruction.16 The SPH does not state that these bacte-
rial species are responsible for all forms of periodontal
disease, but rather that they are responsible for a mea-
surable amount of the tissue destruction with the ex-
pectation that this amount will be biologically and
clinically significant. Implicit in the SPH is the concept
of nondisease-associated plaque.17 For practical pur-
poses the nondisease-associated plaque is simply plaque
which is not colonized and/or dominated by the known
or suspected periodontopathogens. It can be readily
identified by microscopic examination as plaque that is
dominated by cocci and nonmotile rods.718
BPB species, such as Bacteroides gingivalis and Bac-
teroides intermedius, and spirochetes are invariably
elevated in periodontopathic plaques to the extent that
if they are not contributors to the pathogenesis, they at
least are diagnostic indicators of active disease.1019 All
the known oral species of BPB and spirochetes are
anaerobes which suggests that antimicrobial treatment
directed specifically against anaerobes might be effec-
tive in periodontal therapy. The efficacy of the antipro-
tozoa agent metronidazole in acute necrotizing gingi-
vitis (ANUG)20 led to the discovery that metronidazole
has a unique bacteriocidal action against anaerobes.21
Subsequently it was shown that the curative effect of
metronidazole in ANUG was associated with the sig-
nificant and sustained suppression of spirochetes and
 intermedius in plaque samples removed from the
ANUG lesions.22
This action of metronidazole against the type of
anaerobes associated with active Periodontitis led to a
clinical trial of metronidazole in selected Periodontitis
patients.10 A 1-week treatment of metronidazole with
and without scaling was associated with a sustained
suppression of  gingivalis and spirochetes for periods
of 6 months or more. In addition the sites with an
initial probing depth of 6 mm or more exhibited a
probing depth reduction of 2 mm or more and an
apparent attachment gain of 1.5 mm.10 In a study
conducted in Sweden, metronidazole, given for three
2-week periods, each separated by an interval of 8
weeks, was found to give clinical and bacteriological
results comparable to that obtained by rigorous me-
chanical debridement which was delivered in a series
of four visits.23 Both of these clinical studies indicate
that metronidazole may be an antimicrobial agent of
therapeutic value in the treatment of active periodontal
infections.
In the present report, the short-term results of met-
ronidazole treatment plus mechanical debridement in
patients with advanced periodontal disease are pre-
sented, and a double-blind clinical study in which met-
ronidazole plus mechanical debridement is compared
to placebo plus mechanical debridement is described.
MATERIALS AND METHODS
Individuals with clinical evidence of bone loss were
recruited into the study after being diagnosed as having
an anaerobic periodontal infection, i.e., ten per cent
spirochetes in one or more subgingival plaque samples.
They were told of metronidazole's spectrum of activity
against anaerobes and that we were evaluating whether
metronidazole would be efficacious in the treatment of
anaerobic periodontal infections. Patients were advised
of the mutagenicity of metronidazole in bacterial sys-
tems,24 and of the potential adverse reactions of met-
ronidazole with alcohol consumption in some individ-
uals. They were also told that in certain, but not all,
rodent species, lifetime administration of high dosages
of metronidazole, i.e., up to 0.6% of the diet, was
associated with both tumors and longevity.25 26 The
lifetime dosage used in some of the animal studies26
was about 3,500 times the total dosage used in the
present investigation. This therapeutic dosage for hu-
mans has not been associated with human tumors27,28
or with birth defects.29,30 They were told that we were
investigating this usage of metronidazole under an in-
vestigational new drug exemption from the Food and
Drug Administration (FDA).
Metronidazole-Mechanical Groups. Forty patients
with multiple sites of periodontal bone loss were as-
signed to one of two groups depending on the initial
severity of their periodontal condition. If the number
of sites with bone loss was extensive, i.e., an average of
20 or more sites per patient with apparent attachment
loss of 7 mm or more, the patients were placed in an
advanced disease group which received both metroni-
dazole and meticulous root surface debridement. If the
number of sites with bone loss was moderate, i.e. an
average of about 10 sites per patient with attachment
loss of 7 mm or more, the patients were placed into a
double-blind group. The patients in the double-blind
group received the same meticulous root surface de-
bridement as the advanced disease group, but had a
50% chance of receiving either metronidazole or a
placebo medication. All patients were given 21 tablets
containing either metronidazole or placebo (250 mg)
(both metronidazole, Flagyl*, and placebo were gratui-
tously provided by the G. D. Searle Co) at the first
session of root scaling with instructions to take three
tablets a day for 7 days. Compliance was monitored by
history.
This method of patient assignment resulted in three
groups who each received all the mechanical debride-
ment and oral hygiene instruction that was deemed
necessary to bring them successfully through the hy-
gienic phase of periodontal therapy. The groups differed
in that a more severely diseased set of individuals was
known to have received metronidazole (metronidazole-
mechanical group), whereas a less diseased set of indi-
viduals was randomly assigned in a double-blind fash-
ion to either metronidazole (double-blind, metronida-
zole-mechanical group) or to placebo (double-blind
placebo-mechanical group).
Bacteriological Procedures. Subgingival plaque was
removed from one periodontal pocket per quadrant in
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each patient for a total of four samples per patient. The
sites chosen appeared from x-ray examination to be the
most severely involved in each quadrant and were
usually about molar teeth. The supragingival plaque
about the sample site was removed with a curette and
discarded. The root surface was then scaled and the
adherent plaque on the sealer tip was transferred to a
vial containing 0.5 ml of reduced transport fluid (RTF)
without EDTA.31 The plaque sample was immediately
placed within the anaerobic chamber and after dispers-
ing for 20 seconds with a Vortex mixer, a 50 µ aliquot
was removed for microscopic examination. The re-
maining sample was diluted to 4 ml, sonically dispersed
for 20 seconds with a Kontes sonifier,* serially diluted
in RTF and plated automatically with a spiral platerf
on a variety of selective and nonselective media. The
method enabled us to obtain microscopic and cultural
data on the same plaque sample.
The total anaerobic count, the count of BPB species,
Capnocytophaga species, Fusobacterium nucleatum
and Actinomyces odontolyticus were obtained by iden-
tification of their distinctive colonies on enriched tryp-
ticase soy agar (ETSA).32 Either all or representative
colonies of BPB were identified as  gingivalis,  
intermedius and Baeteroides melaninogenicus initially
by their ability to use glucose, to hydrolyze esculin and
to produce indole,22 and subsequently by a rapid test
using chromogenic enzyme substrates.33'34 Actinomyces
viscosus and Actinomyces naeslundii were differentiated
by catalase activity of colonies growing on a selective
GMC agar.35 The total count of facultative organisms,
Streptococcus sanguis and Streptococcus mutans were
obtained from growth on ETSA agar containing 2%
sucrose and 20 Mg/ml of metronidazole, which was
incubated anaerobically. Veillonella colonies were enu-
merated on a medium containing MM 10 base, minus
blood but supplemented with lactate, vancomycin and
a 0.004% bromocresol purple indicator.
Ten µ of the aliquot removed for microscopic ex-
amination was placed on a glass slide, covered with a
22 x 30 mm cover slip, sealed and viewed by dark-field
microscopy. Either 200 organisms or the number of
organisms in 20 high power fields (HPF) were enumer-
ated, depending on which event occurred first. The
single cells were identified as spirochetes, selenomon-
ads, motile rods, fusiforms, nonmotile rods or cocci.7'22
The spirochetes were further subdivided into large,
intermediate and small size spirochetes.
Clinical Evaluation. All teeth, including molars with
furcation involvement, were scored for pocket depth
(probing depth) and loss of attachment using proce-
dures previously described.36 All readings were obtained
by one individual (ECM), who was not aware of the
medications given to participants in the double-blind
study.
* Kontes Glass Co, Vineland. NJ.
t Spiral Systems, Inc, Cincinnati, OH.
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Statistical Analysis. The counts for each organism
enumerated culturally and microscopically were re-
corded on forms suitable for computer processing.
The proportions of these organisms were calculated
by dividing the viable count of the specific organism by
the total viable count on the ETSA agar plate in the
case of the cultural data, and by dividing the micro-
scopic count of the specific organism by the total mi-
croscopic count in the case of the microscopic data. If
there were less than 20 colony-forming units (CFU) on
the ETSA plate or in the microscopic count, no pro-
portions were calculated. This was to eliminate distor-
tions of the data which can occur when the denomi-
nator is very low, as can be the case for microscopic
counts following treatment.
The total counts and the proportions of organisms in
each cultural and microscopic sample were statistically
analyzed using the computer programs available in the
Michigan terminal system. Comparisons between the
placebo and metronidazole samples in the double-blind
study were analyzed by the parametric student t test.
The effect of metronidazole or placebo plus mechanical
debridement on bacterial and clinical parameters
within each group was evaluated by the paired t test.
RESULTS
All patients reported that they used the entire supply
of medication that was provided them. A few patients
noted a metallic taste. Otherwise no complaints were
recorded. Some patients were unable to, or did not,
return for clinical examinations of pocket depth and
attachment loss that were specially scheduled following
completion of the hygienic phase of therapy. This
meant that in some cases we had posttreatment bacte-
riological data for patients in whom we had no post-
treatment clinical measurements. We chose to analyze
all the available bacteriological data within a group, but
to restrict our bacteriological comparisons between
groups to only those subjects for whom we had com-
plete clinical data.
The patients assigned to the known metronidazole
group initially had significantly more sites per dentition
that had pocket depths or attachment loss greater than
7 mm, than did those patients assigned to the double-
blind groups, (Figs. 1 and 2). This increased clinical
involvement was the justification for placement of these
patients into a distinct group.
These advanced-disease patients responded favorably
to treatment in that 15 to 30 weeks after usage of
metronidazole and about 10 to 20 weeks after the
completion of the mechanical debridement of the root
surfaces, the number of pocket sites per patient that
were >7 mm had decreased from 22.8 to 4 (mean
values) and the number of sites with attachment loss
>7 mm decreased from 25.3 to 14.6 (mean values).
The magnitude of this change was greater than that
observed in the double-blind groups (Figs. 1 and 2).
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Figure 2. Frequency distribution ofnumber ofsites with attachment
loss.
Treatment also resulted in a pronounced increase in
the number of sites in which the pocket depths and
attachment loss were <3 mm (Figs. 1 and 2).
Metronidazole treatment in the double-blind patients
reduced the number of pockets that were >7 mm from
12 per patient to 4 per patient (mean values) and the
number of sites with attachment loss >7 mm from 9.7
to 8.8 (mean values). Placebo treatment reduced the
number of pockets that were >7 mm from 8.9 per
patient to 7.7 per patient (mean values) and the number
of sites with attachment loss >7 mm from 11.3 to 10.1
(mean values) (Figs. 1 and 2).
The magnitude of probing depth (pocket) reduction
and the apparent attachment gain in each site found in
these double-blind patients were determined. In sites
that were initially 4 to 6 mm in depth or which exhibited
4 to 6 mm attachment loss, both metronidazole and
placebo treatments caused about a 1-mm decrease in
pocket depth and about a 0.3 mm apparent gain in
attachment (Table 1 ). The slight advantage observed in
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June, 1984
the metronidazole group was not significant. However,
in the deeper pockets and in sites with greater attach-
ment loss, there was a significant advantage associated
with metronidazole treatment (Table 1). Thus while
placebo plus mechanical treatment reduced pocket
depth 1.6 mm and increased attachment gain by 0.3
mm, the metronidazole plus mechanical treatment re-
duced pocket depth by 3.2 mm and increased apparent
attachment gain by 1.4 mm.
The reasons for the apparent clinical effectiveness of
the various treatments were sought in the analysis of
the bacterial composition of the subgingival plaque in
the most clinically diseased site per quadrant. All treat-
ments reduced the levels of bacteria in the plaque
samples as judged by total viable counts on anaerobi-
cally incubated ETSA plates, and by the number of
bacteria observed per high-power field (HPF) of the
darkfield microscope (Table 2). The high viable counts
noted posttreatment in the double-blind metronidazole
group reflected a few very high counts that raised the
mean value, but not the median value. These outlying
Table 1




























* Results are 2 to 4 months after completion of hygienic phase,
t Difference between groups is significant, / test.
Table 2
Effect ofMetronidazole or Placebo Plus Mechanical Debridement
on Size ofPocket Flora
Treatment regimen* Pretreatment
Posttreatment
0-2 wks 15-30 wks
Total Count x 106/
plaque
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
% Facultative
Metro + Mech
DB Metro + Mech




DB Metro + Mech




























* Metro = metronidazole: Mech = mechanical; DB = double-
blind.
 = paired / test: values with these superscripts or  are signifi-
cantly different from other values in row.
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values could be due to the non- or underutilization of
the metronidazole by certain participants.
The patients with advanced disease differed initially
from the double-blind patients in having a reduced
percentage of facultative bacteria in their plaques (Table
2). Treatment in these patients resulted in a significant
increase in the proportions of facultative bacteria that
was still evident 15 to 30 weeks after the administration
of metronidazole. The double-blind patients also ex-
hibited an increase in the proportions of facultative
bacteria as a result of treatment, but this increase was
not significant, probably due to the relatively high
initial proportions of facultative organisms in these
patients (Table 2).
The effect of the various treatments on selected cul-
tivable anaerobes is shown in Table 3. All treatments
resulted in a decrease in the proportions of  interme-
dias in the immediate postmedication period (Table 3).
The reductions observed in the metronidazole groups
were still evident 15 to 30 weeks after treatment,
whereas the reduction in the placebo group did not
persist. All treatments also reduced the proportions of
 gingivalis, but only those in the metronidazole groups
were significant. The proportions of F nucleatum de-
clined significantly following medication in the known
metronidazole group but then significantly increased
15 to 30 weeks later. The proportions ofA odontolyticus
increased following treatment in all groups (Table 3).
The effect of the treatments on selected facultative
or microaerophilic species is shown in Table 4. Metro-
nidazole should not affect these organisms so that a
proportional increase would be expected. This was par-
ticularly evident in the case of S mutans and S sanguis,
but less evident in A viscosus and A naeslundii and not
observed in the case of the Capnocytophaga species
(Table 4). Some of this increase was due to the me-
chanical treatment, as proportional increases were ob-
served in the placebo plus mechanical group, especially
in the proportions of S sanguis. The proportions of A
viscosus, S sanguis and S mutans declined with time
posttreatment. Nevertheless the proportions of S mu-
tans were still elevated from baseline values some 15 to
30 weeks after metronidazole treatment (Table 4).
Spirochetes comprised about 35% of the organisms
in these plaque samples (Table 5). Their proportions
decreased in all treatment groups, but significantly so
only in the metronidazole groups. Fifteen to 30 weeks
after medication, the metronidazole groups still ex-
hibited about a 50% reduction in spirochetes, but the
placebo group had returned to pretreatment values.
The spirochetes were differentiated into large, inter-
mediate and small sizes. Metronidazole significantly
reduced the proportions of large spirochetes in both
groups, often to undetectable levels for the entire period
of observation. The mechanical treatment reduced the
proportions of the large spirochetes initially, but then
Table 3
Effect ofMetronidazole and/or Mechanical Debridement on
Subgingival Proportions ofSelected Anaerobes
Treatment regimen* Pretreat-ment
Posttreatment
0-2 wks 15-30 wks
%  intermedius
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
%  gingivalis
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
% F nucleatum
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
% Veillonella
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
% A odontolyticus
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
[jjj] (40)p 3.4 (40)t 3.1 (32)t
10.0 (35) 2.5 (35) 5.9 (22)



































* Metro = metronidazole; Mech = mechanical; DB = double-
blind.
t Number of plaque samples involved in paired comparison.
 = paired test; values containing these superscripts or  are
significantly different from other values in row.
Table 4
Effect ofMetronidazole and/or Mechanical Debridement on




0-2 wks 15-30 wks
% Capnocytophaga
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
% A viscosus
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
% A naeslundii
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
% 5 sanguis
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
% S mutans
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
1.0 (40)t 0.9 (40)t 1.4 (32)t
4.6 (35) 4.0 (35) 3.0 (22)





































* Metro = metronidazole; Mech = mechanical; DB = double-
blind.
t Number of plaque samples involved in paired comparison.
 = paired ; test; values containing these superscripts or  are
significantly different from other values in row.
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there was a rebound at the 15 to 30-week visit (Table
5).
All treatments significantly reduced the proportions
of intermediate size spirochetes, but this reduction only
persisted in the patients known to have received met-
ronidazole. Metronidazole significantly reduced the
proportions of small spirochetes, whereas only slight
reductions were observed in the placebo group (Table
5).
The effect of the treatments on other morphotypes
that could be distinguished on darkfield microscopy are
presented in Table 6. All treatments caused an imme-
diate increase in cocci, but this increase was only sus-
tained in the known metronidazole patients. The sele-
nomonads decreased in the metronidazole groups
whereas the fusiforms increased in these patients. There
was a significant transient increase in rods in the known
metronidazole patients.
Between-group comparisons were limited to the par-
ticipants in the double-blind study who were present
for both clinical measurements (Figs. 1 and 2). Prior to
treatment these two groups were balanced in terms of
suspected periodontopathic organisms such as  gingi-
valis,  intermedius, F nucleatum, A viscosus, A naes-
lundii and the various spirochetes (Table 7). The pa-
tients destined to receive metronidazole had signifi-
cantly higher proportions of Veillonella, Capnocyto-
phaga species and S mutans.
Zero to 2 weeks after completion of treatment with
either metronidazole or placebo there were significant
Table 5
Effect ofMetronidazole or Placebo Plus Mechanical Debridement
on Subgingival Proportions ofSpirochetes; Microscopic
Examination
Table 6
Effect ofMetronidazole and/or Mechanical Debridement on
Subgingival Organisms; Microscopic Examination
Posttreatment
Treatment regimen* Pretreat-ment 0-2 wks 15-30wks
% Spirochetes
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
% Large spirochetes
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
% Intermediate spirochetes
Metro + Mech
DB Metro + Mech
DB Placebo + Mech
% Small spirochetes
Metro + Mech
DB Metro + Mech


































* Metro = metronidazole; Mech = mechanical; DB = double-
blind.
 = paired / test; values containing these superscripts or cd are
significantly different from other values in row.
Treatment regimen* Pretreatment
Posttreatment
0-2 wks 15-30 wks
% Selenomonads
Metro + Mech 4.5
DB Metro + Mech 10.8
DB Placebo + Mech 5.0
% Motile rods
Metro + Mech 4.9
DB Metro + Mech 4.6 p
DB Placebo + Mech 7.1
% Fusiforms
Metro + Mech 6.4
DB Metro + Mech 4.8
DB Placebo + Mech 7.7
% Rods
Metro + Mech 24.5 p
DB Metro + Mech 26.2
DB Placebo + Mech 28.9
% Cocci
Metro + Mech \u3iP
DB Metro + Mech 16.6































* Metro = metronidazole; Mech = mechanical; DB = double-
blind.
 = paired ; test; values containing these superscripts or  are
significantly different from other values in row.
proportional changes in the plaque flora. The propor-
tions of monitored anaerobes, such as spirochetes (all
sizes),  intermedius and Veillonella, decreased signifi-
cantly in the metronidazole patients relative to the
placebo patients, whereas the proportions of S mutans
and fusiforms increased significantly.
DISCUSSION
Several longitudinal studies have demonstrated that
the maximal effect of mechanical-surgical procedures
on pocket reduction and apparent attachment gain
occurs during or shortly after the completion of active
therapy.37"42 This benefit can be maintained but not
necessarily improved by mechanical debridement deliv-
ered at 2- to 3-month intervals.38 42 If this is so, then a
treatment strategy in periodontics should be to optimize
the initial beneficial effects by tactics that are safe,
effective and cost-efficient. One such tactic would be
the judicious usage of antimicrobial agents in patients
who are diagnosed as exhibiting an active infection or
who are known to be at risk to such an infection.
The rationale behind the usage of antimicrobials in
periodontal disease is valid to the extent that periodon-
tal infections are specific infections.16 In this case short-
term intensive usage of antimicrobials may suppress
the pathogenic flora, so that when the antimicrobial
therapy stops, a nondiseased or normal flora may re-
establish in the subgingival ecosystem. In the present
investigation all patients exhibited elevated proportions
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Table 7




Variable 0-2 wks 15-30 wks
Metro. Placebo Metro. Placebo Metro. Placebo
No. of Plaques 25 30 22
Pocket Depth 5.2 mm 6.2 mm
Attachment Loss 5.4 mm 5.0 mm
Anaerobes
Total Count x IO6 39.3 46.4 42.4
% B. intermedias 6.7 10.2 0.8
%  . gingivalis 9.4 II.6 0.2




















% A. odontolyticus 0.6
% F. nucleatum 2.4
% B. melaninogenicus 4.0
Facultative/Microaerophilic
% Capnocytophaga 2.0
% A viscosus 2.2
% A. naeslundii 0.4
% S. sanguis 2.8














































































































* Values connected by ^ are significantly different by Student / test (S),  = 0.05.
t Signifies that significance  is less than 0.01.
of spirochetes and BPB in their plaques which permitted
us to make a diagnosis of an active anaerobic infection.
The patients differed in the number of sites which
exhibited clinical morbidity such as pocket depth and
attachment loss. It was this extent of morbidity, rather
than obvious bacterial changes, that caused us to rec-
ognize two types of patients, those with numerous sites
of attachment loss (advanced disease), and those with
a moderate number of sites (Figs. 1 and 2). The former
patients were given metronidazole, whereas the latter
were entered into a double-blind study.
The advanced disease patients showed a profound
clinical improvement following 1 week of metronida-
zole and rigorous mechanical debridement (Figs. 1 and
2). How much of this was due to the usage of metro-
nidazole and how much to the mechanical debridement
cannot be stated, other than to note that two of the
patients in this group had, in the past, received complete
conventional periodontal therapy and thus might be
considered as refractory patients. The bacteriological
changes that occurred are consistent with a metroni-
dazole effect as anaerobes such as BPB and spirochetes
were suppressed for 15 to 30 weeks (Tables 3 and 5).
Of particular interest in these patients was the appar-
ent increase in attachment that was detected clinically
with the probe. If these measurements reflect accurately
what is happening at the base of the pocket, then some
of the pocket reduction that occurred in these patients
occurred at the bottom of the pocket. If so, then x-rays
might reflect this change in pocket configuration. Non-
standardized x-rays taken of these patients suggested
that the bone levels about some of these teeth did not
decrease over time and may have improved (Fig. 3).
The patients assigned to the double-blind study were
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similar to the advanced disease patients in terms of the
proportions of spirochetes and BPB in their plaques.
The metronidazole clearly suppressed the proportions
of these indicator-organisms in the subgingival plaque
immediately following medication both relative to pre-
treatment values and to placebo treatment values (Ta-
bles 3, 5 and 7). However, at the 15 to 30 week interval,
only the proportions of the large spirochetes were still
significantly suppressed in the metronidazole group
relative to the placebo group (Table 7). This could
indicate that the continued suppression of these orga-
nisms was contributing to or was responsible for the
improved periodontal health in the metronidazole pa-
tients, or that the higher proportions of these organisms
in the placebo patients were an early indicator of recur-
rence of an infection. In this regard it should be noted
that only a few of the many anaerobic species present
in plaque43 are identified by our bacteriological ap-
proach. Thus unidentified anaerobes such as Eubacter-
ium species and Peptostreplococcal species43 should
have been suppressed by the metronidazole, but the
duration of this suppression is not known.
Metronidazole is not an antiplaque agent. In fact,
metronidazole should select for plaque-forming orga-
nisms such as S mutans, S sanguis, A viscosus and A
naeslttndii, because these organisms are microaero-
philic and/or facultative. This occurred in the short run
for 5 mutans, S sanguis and A viscosus, but with the
exception of S mutans this selection was not evident in
plaques removed 15 to 30 weeks after medication.
The patients destined to receive metronidazole ini-
tially had low proportions of S mutans, but the propor-
tions were significantly higher than those found in
patients destined to receive placebo (Table 7). Metro-
nidazole led to a large proportional increase in S mutans
in those plaques removed 0 to 2 weeks after medication,
and this increase, while somewhat subdued, was still
evident some 15 to 30 weeks after the metronidazole
(Table 7). This selection for S mutans was without
apparent clinical significance in our patients but does
indicate that the usage of metronidazole in caries-active
patients might be contraindicated, or that supplemental
topical fluoride treatments should be used.
The Capnocytophaga species and A actinomycetem-
comitans are also resistant to metronidazole. The levels








Figure 3. X-rays of 19-year-old patient with generalized bone loss about molars and premo/ars when seen in November of 1979. Patient was
treatedfor 1 week with metronidazole and had teeth mechanically debrided in November 1979. X-rays taken 1 year later suggest that no further
bone loss occurred. The large carious lesion in the upper right first molar was restored.
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increased transiently in the plaques immediately follow-
ing therapy. A actinomycetemcomitans was not found
in these patients either before or after treatment.
At the 15- to 30-week interval, the proportions of
certain anaerobes such as F nucleatum, A odontolyticus
and Veillonella had increased proportionately in the
metronidazole group relative to the placebo group (Ta-
ble 7). As this increase was associated with a sustained
clinical improvement in the metronidazole patients,
these anaerobes would appear to be members of the
nondisease flora.
The placebo plus mechanical treatment also ex-
hibited some degree of selectivity against anaerobes.
Thus the proportions of both  intermedius and  
gingivalis (Table 3) and total spirochetes decreased
initially (Table 5). However this reduction was not
sustained. Ongoing studies in our laboratory involving
other patients indicated that rigorous mechanical de-
bridement selectively decreases the proportions of BPB
and spirochetes.44 Thus it may be that nonspecific
Figure 4. X-rays of28-year-oldpatient taken in February 1981 (top ro
anterior teeth, 4c, maxillary teeth. Patient received metronidazole for
rays taken in 1983 suggest that no further bone loss occurred.
treatments such as scaling and root planing are success-
ful because in practice they discriminate against anaer-
obes and select for a facultative flora. If so, then their
mechanism of action is comparable to the mechanism
of action of metronidazole, i.e. the conversion of a
periodontopathic flora to a nondisease-associated flora
by the selective deletion of certain anaerobic organisms.
This similarity of mechanism could explain why the
metronidazole and placebo treatments were essentially
equivalent in the clinical resolution of pockets initially
4 to 6 mm in depth (Table 1). The mechanical treat-
ment could be delivered at these pocket depths with
such effectiveness that only a minimal additional bene-
fit could be derived from the metronidazole. However
at pockets greater than 6 mm, the efficacy ofmechanical
debridement decreases due to instrument inaccessibility
of deep root surfaces and furcations. These sites how-
ever are apparently bathed by sufficient levels of met-
ronidazole to effect a significant improvement in ap-
parent attachment gain and pocket reduction (Table 1).
>) and in March of1983 (bottom row). 4a, mandibular teeth, 4b, maxillary
week and had teeth mechanically debrided in the spring of 1981. The x-
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About half of the pocket reduction in these deep
pockets in the metronidazole patients was associated
with an apparent gain of attachment of about 1.4 mm,
whereas in the placebo group the apparent gain in
attachment contributed minimally to the pocket reduc-
tion (Table 1). This suggests that the metronidazole
permitted a type of disease resolution in the base of
these deep pockets which was not found with mechan-
ical debridement plus placebo. Again, nonstandardized
x-rays were suggestive of bone fill about some of the
teeth in these patients (Fig. 4). The implication of this
finding caused us to terminate the present study and to
initiate a second double-blind study in which standard-
ized x-rays would be taken45 and then analyzed by
subtraction radiography46 in order to assess any change
in bone levels and/or density.
In conclusion, the results reported in this investiga-
tion indicate that short-term usage of systemic metro-
nidazole can optimize the clinical reduction of pockets
and increase attachment gain in Periodontitis patients
who receive concurrent mechanical debridement of
their root surfaces. In the case ofpatients with extensive
clinical involvement, the metronidazole treatment re-
sults in a significant reduction in the number of sites
exhibiting pocket depths and attachment loss >7 mm.
When metronidazole plus mechanical debridement was
compared with placebo plus mechanical debridement
in a double-blind study, the metronidazole patients
exhibited a significant improvement in those sites ini-
tially >7 mm. In both the advanced Periodontitis pa-
tients and the double-blind patients, the beneficial effect
of the metronidazole was associated with a significant
and sustained reduction of certain anaerobic organisms
such as  gingivalis and the large spirochetes. These
data indicate that the periodontal infections present in
these patients had a dominant anaerobic component.
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Dr. Frank Wentz, 67, a life member of the Academy of Periodontology, passed away
January 8, 1984.
Dr. Wentz received his DDS degree from Temple University in 1939, his Masters
degree in dental histology in 1948 and his PhD in anatomy and pathology in 1954 from
the University of Illinois. He embarked on an academic career which spanned 30 years
of outstanding accomplishments in periodontics. Clinical application of biologic infor-
mation was the subject of most of his many scientific articles and numerous textbook
contributions.
The measure of Dr. Wentz's enthusiasm for knowledge and universal curiosity was
manifest in 1977 when he was stricken with an undiagnosed disease which left him
paralyzed. He perceived the disability as just another challenge to be conquered and
proceeded with his productive career in teaching, administration and scholarly pursuits.
